Yandex forecasts industrial revolution in 2020sScience & Space September 21, 17:36
Over 3,000 people evacuated from Yandex office over bomb threatSociety & Culture September 21, 17:24
Warsaw’s Soviet Military Cemetery cleared after vandal attackWorld September 21, 17:19
Russian premier slams EU position on Nord Stream 2Business & Economy September 21, 17:13
Tver gunman asks court to reduce his life sentence to 25 years in prisonSociety & Culture September 21, 17:02
Swedish King’s cousin plans to make wine in CrimeaSociety & Culture September 21, 17:01
Over 3,000 people evacuated over bomb threats in Moscow museums, legendary film studioSociety & Culture September 21, 16:39
Putin says Russian economy overcomes recessionBusiness & Economy September 21, 16:14
Police beef up security as migrants flock to Moscow shopping centerSociety & Culture September 21, 15:58
REDMOND, Washington, Sept. 10, 2013 /PRNewswire/ -- Worldwide validation for dietary supplement technology that protects probiotics from stomach acid and provides controlled, extended release of live organisms to the intestines. Patents have now been granted in more than 30 countries for Nutraceutix's "Delivery System for Biological Component", trademarked as BIO-tract®. This now includes the 24 countries in the European Patent Convention, in addition to Australia, Canada, Singapore, Japan, Hong Kong, Republic of Korea, People's Republic of China, the Russian Federation and the United States. Additional patents in the U.S. and Canada are pending.
The European Patent Convention includes: Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Monaco, The Netherlands, Portugal, Slovakia, Spain, Sweden, Switzerland, Turkey, and the United Kingdom.
Unlike powders, capsules and cultured foods, BIO-tract tablets offer protection from damaging stomach acids, then gently release live organisms over time to the upper and lower intestinal tracts for heightened effectiveness. BIO-tract also takes advantage of Nutraceutix's patented LiveBac® processing to extend probiotic shelf life far beyond other supplemental forms, even at room temperature.
"Our growing, global patent portfolio documents BIO-tract's technical superiority," asserts Tim Gamble, President and CEO of Nutraceutix. "For years, BIO-tract has been a recognized hallmark of quality and is now becoming the industry standard for premium probiotics and other ingredients that benefit from its unique capabilities. It is the only probiotic dietary supplement format that offers such a stellar combination of effective delivery and stability with outstanding formulation and packaging flexibility."
Headquartered in Redmond, Washington, Nutraceutix is an NSF Certified GMP contract manufacturer and private labeler of probiotics and other premium nutritional supplements. The company specializes in producing high-quality probiotics in bulk powder, capsules and tablets from its broad, factory-direct offering of natural probiotic organisms. Nutraceutix's pioneering achievements and unequalled collection of patented processes and technology were recognized by Frost and Sullivan in 2010 with a North American "Technology Innovation of the Year" award.
Nutraceutix Sales and Marketing team